A Study of PRT2527 in Participants With Advanced Solid Tumors

Clinical trial NCT05159518 · COMPLETED

Trial details

NCT number: NCT05159518
Sponsor: Prelude Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sarcoma Castrate Resistant Prostate Cancer Hormone Receptor Positive HER2 Negative Breast Cancer Non-small Cell Lung Cancer Solid Tumors With Known MYC Amplification

Start date: 2022-02-14
Primary completion: 2023-12-06
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.